Search for Clinical Trial Results

Sponsored By

Cholangiocarcinoma - 68 Studies Found

Status Study
Completed Study Name: VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway
Condition: Intrahepatic Cholangiocarcinoma
Date: 2013-08-05
Interventions: Procedure: surgical treatment all the patients in the study must have been treated by the surgery at the
Withdrawn Study Name: Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
Condition: Cholangiocarcinoma
Date: 2008-01-17
Withdrawn Study Name: VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)
Condition: Extrahepatic Cholangiocarcinoma
Date: 2014-03-31
Interventions: Procedure: surgical treatment all the patients in the study must have been treated by the surgery at the
Active, not recruiting Study Name: Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Condition: Cholangiocarcinoma
Date: 2014-07-02
Interventions: Drug: Nab-Paclitaxel and Gemcitabine Nab-Paclitaxel will be administered first, at a dose of 125 mg/m
Completed Study Name: Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
Condition: Cholangiocarcinoma
Date: 2010-09-20
Interventions:
  • Drug: Gemcitabine 1,000 mg/m2

Completed Study Name: Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Date: 2014-07-03
Interventions: Other: exposure to different risk factors and molecular assessment
Completed Study Name: Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients
Condition: Intrahepatic Cholangiocarcinoma
Date: 2013-07-31
Interventions:
  • Procedure: Resection
  • Radiation: Radiothera
Terminated Study Name: A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Condition:
  • Unresectable Intrahepatic Cholangiocarcinoma
  • Resectable Date: 2014-09-25
    Interventions:
    • Drug: Gemcitabine Other Name:

Completed Study Name: 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Date: 2015-07-29
Interventions:
  • Device: SIR-Spheres microspheres (Yttrium-90 Microspheres)

Not yet recruiting Study Name: Liver Transplantation for Early Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Date: 2016-08-17
Interventions: Procedure: Deceased donor Liver Transplantation Deceased donor orthotopic liver transplantation
<<< Previous | Next >>>